TW240225B - - Google Patents

Info

Publication number
TW240225B
TW240225B TW81106969A TW81106969A TW240225B TW 240225 B TW240225 B TW 240225B TW 81106969 A TW81106969 A TW 81106969A TW 81106969 A TW81106969 A TW 81106969A TW 240225 B TW240225 B TW 240225B
Authority
TW
Taiwan
Application number
TW81106969A
Other languages
Chinese (zh)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/755,747 external-priority patent/US5296487A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW240225B publication Critical patent/TW240225B/zh

Links

TW81106969A 1991-09-06 1992-09-02 TW240225B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/755,747 US5296487A (en) 1990-01-02 1991-09-06 Quinazoline derivatives and their preparation

Publications (1)

Publication Number Publication Date
TW240225B true TW240225B (https=) 1995-02-11

Family

ID=51400831

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81106969A TW240225B (https=) 1991-09-06 1992-09-02

Country Status (1)

Country Link
TW (1) TW240225B (https=)

Similar Documents

Publication Publication Date Title
DE4290261T1 (https=)
DK0498143T3 (https=)
DE4291719T1 (https=)
DE4292255T1 (https=)
DE4291827T1 (https=)
DK0539725T3 (https=)
DE4291721T1 (https=)
DK0511526T3 (https=)
ATA181891A (https=)
DE4193594T1 (https=)
TW240225B (https=)
ECSM91543U (https=)
DK132791D0 (https=)
ECSDI910041S (https=)
ECSDI910049S (https=)
ECSM91533U (https=)
ECSM91556U (https=)
ECSM91561U (https=)
AU8114391A (https=)
AU8480391A (https=)
AU8979091A (https=)
AU8983291A (https=)
AU8997191A (https=)
CN3008237S (https=)
CN3009643S (https=)